summari close report disappoint
result due top-lin miss narrow top-lin
guidanc howev compani abl beat bottom-
line rais ep guidanc primarili lower tax rate
report ep ahead consensu
estim ep beat reflect lower tax rate despit
shortfal top-lin latter due part brexit-
relat destock compani narrow sale guidanc
midpoint rang rais full year ep
outlook midpoint rang midpoint
coopervis csi coopersurg continu
target low-doubl digit ex-fx oper incom growth
combin lower interest expens higher tax rate see
ep growth mid- high-singl digit rang next year
final manag sound confid misight us approv
could come end would view
import strateg posit despit neg short-term impact
 chang ep estim
lower ep estim lower
price target base ep
estim
multifoc result
ep beat lower tax rate report total
revenu pro forma growth consensu
estim due softer sale
csi sale miss estim due
competit pressur inventori destock associ
brexit uncertainti pro forma growth slow due
tougher comp growth stack basi rel
stabl around csi sale miss
estim due soft paragard flattish yr/yr
believ reduc promot activ inventori
reduct led weaker paragard result csi growth slow
also due tougher yr/yr comp despit top-lin miss
ep exceed consensu estim
driven lower-than-expect tax rate vs
estim gross margin oper margin
larg in-lin model
continu next page
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
compani data secur llc estim reuter
compani data secur llc estim reuter
continu previou page
guidanc narrow lower midpoint total revenu guidanc
pro forma growth lower low-end rang bottom-lin
compani rais low-end ep guidanc new rang
midpoint rang ep guidanc rais reflect lower tax rate lower
interest expens reduc fx headwind partli off-set increas invest spend
misight full year tax rate expect nearli lower vs previou quarter
sale growth expect acceler guid total revenu
pro forma growth compani expect sale pro forma growth
repres stabl slightli improv growth vs csi expect sale
pro forma growth midpoint repres acceler
midpoint guidanc rang top-lin growth expect acceler busi
expect growth normal emea growth america apac continu
improv slightli csi compani believ paragard inventori normal could see
small benefit near-term price increas guid tax rate ep
believ guidanc reason potenti upsid ep lower tax rate
final anticip hike japanes consumpt tax octob lead buy-in
japan septemb benefit expect mostli revers octob thu mitig real
benefit
misight us approv could come end call manag report continu
convers fda misight contact len myopia manag seem suggest
file file near-term agenc manag sound confid
may posit updat misight us end anticip approv
compani acceler invest spend prepar launch includ salesforc expans
market educ report strong demand misight ou market like europ asia
sale len doubl yr/yr
expect continu outperform market base aggreg contact len result
alc bhc estim global contact len market grew closer
adjust jnj brexit-rel destock compar growth closer
adjust jnj brexit-rel stock seem consist manag expect
overal contact len market continu grow rang perhap even upper
half rang driven continu trade sihi silicon hydrogel daili expect
outpac growth continu grow rang larg driven sihi daili franchis
compani face capac constraint myday product line due acceler demand
new product line order take time ramp addit capac capac
issu also affect time coo myday multifoc introduct help compani
remain competit segment launch
estim mid- high-singl digit ep growth expect busi
continu grow rang overal contact len market grow toward upper end
histor rang believ growth outlook applic call manag
reiter target grow oper incom low-doubl digit ex-fx howev compani
note potenti acceler invest relat misight len approv fda
manag continu expect tax rate compar expect year
expect lower interest expens continu debt reduct lower interest rate partli off-set
meaning step tax rate put togeth impli ep growth mid- high-singl
digit exclud fx impact compani histor manag tax rate lower
could repres sourc earn upsid stock option exercis benefit addit
note uncertainti associ brexit could continu affect next coupl
price target
price target base ep estim risk includ slower growth
contact len market increas competit stronger dollar
particip attract contact len market sale grow
strong portfolio lens across modal help compani continu take share
global medic devic compani develop manufactur market health care
product two divis coopervis produc contact lens account
revenu coopersurg women health busi contribut nearli revenu
coopervis tie player nearli share billion global soft contact len
market revenu grew pro forma billion million
